Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-30 4:42 pm Unchanged |
2022-09-27 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 3,940,413 11.100% |
0 (Unchanged) |
Filing History |
| 2022-08-15 5:06 pm Sale |
2022-08-15 | 13G | CYTEIR THERAPEUTICS INC CYTT |
RA Capital Management, L.P. | 0 0.000% |
-3,350,506 (Position Closed) |
Filing History |
| 2022-07-22 6:37 pm Sale |
2022-07-20 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 3,940,413 11.100% |
-900,000 (-18.59%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
RA Capital Management, L.P. | 3,350,506 9.500% |
103,389 (+3.18%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
Venrock Associates VII L.P. | 3,259,022 9.200% |
3,259,022 (New Position) |
Filing History |
| 2022-02-14 4:02 pm Purchase |
2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
Lightstone Ventures II L.P. | 2,444,265 6.900% |
2,444,265 (New Position) |
Filing History |
| 2022-02-11 6:07 pm Purchase |
2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
Avidity Partners Management LP | 1,849,538 5.200% |
1,849,538 (New Position) |
Filing History |
| 2022-02-11 3:29 pm Purchase |
2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
JANUS HENDERSON GROUP PLC JHG |
1,872,421 5.300% |
1,872,421 (New Position) |
Filing History |
| 2022-02-09 09:11 am Sale |
2022-02-08 | 13G | CYTEIR THERAPEUTICS INC CYTT |
FMR CORP | 4,048,993 11.447% |
-236,666 (-5.52%) |
Filing History |
| 2022-02-03 4:45 pm Purchase |
2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
Osage University GP II LLC | 2,474,572 7.000% |
2,474,572 (New Position) |
Filing History |
| 2021-12-20 1:00 pm Unchanged |
2021-12-15 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 4,840,413 13.600% |
0 (Unchanged) |
Filing History |
| 2021-10-12 09:25 am Purchase |
2021-10-08 | 13G | CYTEIR THERAPEUTICS INC CYTT |
FMR CORP | 4,285,659 12.116% |
4,285,659 (New Position) |
Filing History |
| 2021-06-29 4:33 pm Purchase |
2021-06-22 | 13G | CYTEIR THERAPEUTICS INC CYTT |
RA Capital Management, L.P. | 3,247,117 9.400% |
3,247,117 (New Position) |
Filing History |
| 2021-06-25 4:33 pm Purchase |
2021-06-17 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 4,840,413 14.000% |
4,840,413 (New Position) |
Filing History |